Prime Medicine's layoffs are part of a pattern. At least a half-dozen gene-editing companies have laid off staff in the past ...

Thomas Fuchs will lead AI initiatives across Lilly, including in drug discovery, clinical trials and manufacturing.

The latest deal in AI drug discovery is a twist on the usual big pharma-startup collaboration model, with Insitro licensing ...

In a departure from most deals, startup insitro will in-license Lilly’s delivery technology for its investigational ...

Eli Lilly said Wednesday it will invest $4.5 billion to build an advanced pharmaceutical drug manufacturing and development facility in Lebanon, Indiana expected to open in late 2027. Fatty liver ...

Insitro has teamed up with Eli Lilly to help power programs into the clinic, tapping the Big Pharma for an option on ...

Machine-learning drug development company Insitro has inked three agreements with Eli Lilly for new medicines for metabolic ...

SOUTH SAN FRANCISCO, Calif., October 09, 2024--insitro and Lilly Enter Strategic Agreements to Advance Novel Treatments for Metabolic Diseases ...

As that figure was large, weight loss drug producer Eli Lilly (NYSE: LLY) saw a nearly 2% bump in its share price in response ...

A trade group for large compounding pharmacies sued the FDA over its move to take Eli Lilly’s blockbuster GLP-1 drug off its ...

Indianapolis-based Eli Lilly’s supply of Mounjaro, which is used to treat Type 2 diabetes, and popular weight-loss drug ...

Eli Lilly, the pharmaceutical giant behind some of the most successful drugs in recent years, has announced plans to invest ...